Related Experiment Video
Updated: Aug 10, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
[A case of chronic hepatitis C complicated by ischemia-like changes seen on the electrocardiogram during interferon
K Yamazaki1, M Amishima, J Fujita
1First Department of Medicine, Hokkaido University, School of Medicine.
Insights
Interferon (IFN) alpha 2a treatment for chronic hepatitis C may trigger coronary microvessel spasms, causing chest pain and ECG changes. Symptoms resolved after discontinuing IFN, suggesting a link between the therapy and cardiac events.
Area of Science:
- Cardiology
- Hepatology
- Pharmacology
Background:
- Chronic hepatitis C is a significant global health concern.
- Interferon (IFN) alpha 2a is a therapeutic agent used in managing chronic hepatitis C.
- Understanding potential adverse cardiac events associated with IFN therapy is crucial for patient safety.
Observation:
- A 53-year-old woman presented with chest pain, headache, nausea, and vomiting post-intramuscular injection of IFN alpha 2a.
- Electrocardiogram (ECG) revealed ST depression and T inversion, indicative of myocardial ischemia.
- Coronary angiography, cardiac enzymes, and imaging studies did not reveal obstructive coronary artery disease or myocardial infarction.
Findings:
- The patient's symptoms and ECG abnormalities resolved upon cessation of IFN alpha 2a treatment.
- Recurrence of similar ECG changes during provocative testing (exercise and hyperventilation) post-recovery.
- Diagnosis of coronary microvessel spasms, potentially triggered by IFN alpha 2a, was established.
Implications:
- IFN alpha 2a may induce coronary microvessel spasms, leading to ischemic symptoms.
- This case highlights the importance of considering IFN-induced cardiac adverse effects in patients with hepatitis C.
- Further research is warranted to elucidate the mechanisms and prevalence of IFN-associated coronary microvascular dysfunction.
Abstract:
A 53-year-old woman was admitted to the hospital for chest pain with headache, nausea and vomiting, two and a half hours after an intramuscular injection of 6 x 10(6) units of IFN (interferon) alpha 2a, in the 11th week of IFN treatment for chronic hepatitis C. The electrocardiogram (ECG) showed ST depression and T inversion in leads II, III, aVF and V3-V6, as commonly seen in myocardial ischemia. However, emergency coronary angiography (CAG) did not show stenosis or spasms clearly, serum CPK was always within the normal limits, Tc-99m PYP scintigraphy and T1-201 scintigraphy did not show any abnormal uptake or defect, and the echocardiogram did not show any abnormality. She recovered from chest pain and the ischemia-like changes seen on the ECG, after IFN treatment was stopped, and she rested for 7 days from this treatment and other treatment using nitrites and a calcium-antagonist. After recovery, the ECG during exercise and hyperventilation showed changes similar to those seen on admission. From these findings, this case was considered to be precipitated by spasms of coronary microvessels, which were not noticeable in CAG. The cause was thought to be complicated by IFN treatment, because this episode appeared after IFN injection, and improved after stopping IFN treatment.
More Related Videos
Related Concept Videos
Myocarditis I: Introduction
Myocarditis III: Medical Management
Heart Failure IV: Classification and Diagnostic Evaluation
Hepatitis
Cirrhosis I: Introduction
Hepatic Encephalopathy

